Elekta AB (publ) Stock Forecast, Price & News

+0.22 (+1.59 %)
(As of 06/24/2021 03:33 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume3,889 shs
Average Volume3,087 shs
Market Capitalization$5.37 billion
P/E Ratio36.97
Dividend Yield1.08%
30 days | 90 days | 365 days | Advanced Chart
Receive EKTAY News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Elekta AB (publ) logo

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.13 out of 5 stars

Medical Sector

1038th out of 2,105 stocks

Medical Laboratories Industry

17th out of 40 stocks

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Elekta AB (publ) (OTCMKTS:EKTAY) Frequently Asked Questions

Is Elekta AB (publ) a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last year. There are currently 2 sell ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Elekta AB (publ) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EKTAY, but not buy additional shares or sell existing shares.
View analyst ratings for Elekta AB (publ)
or view top-rated stocks.

What stocks does MarketBeat like better than Elekta AB (publ)?

Wall Street analysts have given Elekta AB (publ) a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Elekta AB (publ) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Elekta AB (publ)?

Elekta AB (publ) saw a increase in short interest in May. As of May 14th, there was short interest totaling 3,100 shares, an increase of 138.5% from the April 29th total of 1,300 shares. Based on an average trading volume of 4,400 shares, the short-interest ratio is presently 0.7 days.
View Elekta AB (publ)'s Short Interest

When is Elekta AB (publ)'s next earnings date?

Elekta AB (publ) is scheduled to release its next quarterly earnings announcement on Wednesday, August 25th 2021.
View our earnings forecast for Elekta AB (publ)

How were Elekta AB (publ)'s earnings last quarter?

Elekta AB (publ) (OTCMKTS:EKTAY) issued its quarterly earnings results on Friday, May, 28th. The company reported $0.11 EPS for the quarter. The firm had revenue of $436.95 million for the quarter, compared to analysts' expectations of $454.96 million. Elekta AB (publ) had a net margin of 9.14% and a trailing twelve-month return on equity of 15.80%.
View Elekta AB (publ)'s earnings history

How has Elekta AB (publ)'s stock been impacted by Coronavirus?

Elekta AB (publ)'s stock was trading at $9.29 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EKTAY stock has increased by 51.2% and is now trading at $14.05.
View which stocks have been most impacted by COVID-19

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) declared a dividend on Thursday, April 15th. Shareholders of record on Tuesday, April 20th will be given a dividend of $0.2089 per share on Monday, May 10th. This represents a dividend yield of 1.52%. The ex-dividend date of this dividend is Monday, April 19th.
View Elekta AB (publ)'s dividend history

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) pays an annual dividend of $0.15 per share and currently has a dividend yield of 1.08%. The dividend payout ratio of Elekta AB (publ) is 39.47%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 28.30% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend.
View Elekta AB (publ)'s dividend history.

Who are Elekta AB (publ)'s key executives?

Elekta AB (publ)'s management team includes the following people:
  • Dr. Laurent Leksell, Founder & Chairman (Age 69)
  • Mr. Gustaf Salford, Pres & CEO (Age 44)
  • Mr. Johan Adeback, CFO & Group Treasurer (Age 57)
  • Cecilia Ketels, Head of Investor Relations
  • Mr. Jonas Bolander, Gen. Counsel, Sec. & Exec. VP (Age 55)
  • Mr. Mattias Thorsson, VP Corp. Communications & Public Affairs
  • Ms. Karin Svenske Nyberg, Exec. VP of HR (Age 55)
  • Mr. James P. Hoey, Head of External Relations (Age 63)
  • Mr. John Lapré, Pres of Brachy Solutions (Age 57)
  • Mr. Maurits Wolleswinkel, Pres Linac Solutions & Chief Product Officer (Age 50)

Who are some of Elekta AB (publ)'s key competitors?

What is Elekta AB (publ)'s stock symbol?

Elekta AB (publ) trades on the OTCMKTS under the ticker symbol "EKTAY."

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elekta AB (publ)'s stock price today?

One share of EKTAY stock can currently be purchased for approximately $14.05.

How much money does Elekta AB (publ) make?

Elekta AB (publ) has a market capitalization of $5.37 billion and generates $1.57 billion in revenue each year. The company earns $143.46 million in net income (profit) each year or $0.38 on an earnings per share basis.

How many employees does Elekta AB (publ) have?

Elekta AB (publ) employs 4,265 workers across the globe.

What is Elekta AB (publ)'s official website?

The official website for Elekta AB (publ) is www.elekta.com.

Where are Elekta AB (publ)'s headquarters?

Elekta AB (publ) is headquartered at P.O. Box 7593, Stockholm V7, SE-103 93.

How can I contact Elekta AB (publ)?

Elekta AB (publ)'s mailing address is P.O. Box 7593, Stockholm V7, SE-103 93. The company can be reached via phone at 46-8-587-254-00 or via email at [email protected]

This page was last updated on 6/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.